CHEWY, INC. (CHWY): what the price requires
At today's price, CHEWY, INC. (CHWY) is priced for +33.5% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Source: https://boothcheck.com/report/CHWY
Headline
| Field | Value |
|---|---|
| Ticker | CHWY |
| Company | CHEWY, INC. |
| Current price | $20.35/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 0.9% |
| Operating margin today | 2.7% |
| Margin compression implied | -1.8pp |
| Implied growth | 33.5% |
| Multiple paid | 25x operating income |
The operating-margin requirement is derived from the framework's value band at year 8, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 11.6% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.4pp.
Reconcile: at the x-ray's 9.3% required return this reads ~20.6%/yr; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| cohort percentile (of 212 peers) | 70 |
| sustained it ~5 years at this level | 23% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.09x | 5 | expensive |
| Earnings | 2.31x | 4 | expensive |
| Relative | 1.40x | 5 | expensive |
| Growth | 0.85x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.
Per-Model Detail (n=17)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $35.62 | 0.57x | yes | FCF base $0.6B, growth 6% (input: historical growth), terminal g 4.0%, WACC 8.2%, 6yr projection |
| DCF Exit Multiple | Growth | $24.01 | 0.85x | yes | Exit EV/EBITDA: 18.6x / 20.6x / 22.6x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $14.51 | 1.40x | yes | P/E 24.03x (blended: static sector reference 20x + trailing (TTM) 33x), scenarios: 20.1x / 24.0x / 28.0x (bear / base = reference held flat / bull), EV/EBITDA 14x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $6.58 | 3.09x | yes | BV/sh $1.01, ROE (TTM) 60.2%, ke 9.3% |
| Two-Stage Excess Return | Asset | $22.73 | 0.90x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $16.15 | 1.26x | yes | Rev $12.8B, growth 6% (input: historical growth; tapered), Terminal P/S: 0.6x / 0.7x / 0.8x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $7.20 | 2.83x | yes | EPS $0.60, growth 2% (input: historical EPS growth), PEG=16.71 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $0.37 | 55.00x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.08B × (1−28%) / WACC 8.2% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $10.81 | 1.88x | yes | BV $1.01 + 5yr PV of (ROE (TTM) 60.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $3.70 | 5.50x | yes | √(22.5 × EPS $0.60 × BVPS $1.01) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $13.40 | 1.52x | yes | EBITDA $0.44B × sector EV/EBITDA 14.0x |
| FCF Yield | Earnings | $13.71 | 1.48x | yes | FCF $584.5M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $6.22 | 3.27x | yes | SBC-adj FCF $0.29B (FCF $0.58B − SBC $0.29B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $19.36 | 1.05x | yes | EPS $0.60 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $1.14 | 17.85x | yes | BV $1.01 × (ROIC 9.3% / WACC 8.2%) |
| P/Sales Sector | Relative | $45.97 | 0.44x | yes | Revenue $12.84B × sector P/S 1.5x |
| PEG Fair Value | Relative | $22.50 | 0.90x | yes | EPS $0.60 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $6.49 | 3.14x | yes | EPS $0.60 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $520.1m |
| Net debt / NOPAT (after-tax) | -2.12x (net cash) |
| Net debt / operating income (pre-tax) | -1.53x (net cash) |
| Interest coverage | 64.2x |
| Share count CAGR (buyback) | -0.4% |
| Burning cash | no |
Bullet Takeaways
- Online retail is hard to value because the margins are thin and the durability is everything. At Chewy, the Autoship subscription program drives 84.4% of net sales, the recurring base that the static valuation methods cannot fully price.
- The price at $18.21 is reached by only the growth methods. Asset, earnings-power, and most peer frames sit below it, so the quote is a bet on durable compounding, with the reverse-DCF reading an implied growth requirement near 29%.
- The business is profitable and debt-free: Q1 2026 net sales grew 7.7% to about $3.6 billion, adjusted EBITDA margin hit a record 7.5%, and the company holds $520 million of net cash. The question is whether modest customer growth can sustain a premium multiple.
Bull Case
Valuing an online retailer is its own puzzle, because the reported margins are thin and the entire question is how durable the revenue is. Chewy is the cleanest illustration of why durability is the point. The company derives net sales primarily from pet food, products, medications, and health items, sold heavily through its Autoship subscription program (FY2024 10-K, accession 0001766502-25-000014), and Autoship now represents 84.4% of total net sales, growing over 10% year over year in Q1 2026. That is not transactional e-commerce; it is a recurring-revenue base in a category, pet care, where spending is non-discretionary and habitual. A 2.4% operating margin understates the economics of a business where most of the revenue reorders itself automatically.
The static valuation methods cannot fully price that durability, which is exactly why only the growth frames reach the price. The reverse-DCF characterizes the bet as a durability premium the static frames structurally cannot capture. With a 60% trailing return on equity on a tiny book value, the business is generating strong returns on the capital it employs, and it is doing so with no debt.
The financial profile backs the premium. Q1 2026 net sales grew 7.7% to roughly $3.6 billion, adjusted EBITDA margin expanded 130 basis points to a record 7.5%, and the company added nearly 200,000 net active customers to reach 21.5 million. Chewy holds $520 million of net cash, generates real free cash flow, and is expanding margin while it grows. The bull case is that a sticky, automated, non-discretionary revenue base with widening margins and a clean balance sheet deserves to trade on its forward compounding, not on the thin trailing margin the asset and earnings methods see.
Bear Case
The moat is the whole bull case, and it is being chipped at from both ends of the market. Chewy's own filing is blunt that competition in pet products and services, especially Internet-based competition, is strong and presents an ongoing threat, and that it competes with online and traditional pet pharmacies that may hold advantages from longer operating histories, established brand names, and greater resources (FY2024 10-K, accession 0001766502-25-000014). Translated, that is Amazon and Walmart on price and convenience at the top, and entrenched pet pharmacies on the health and prescription side. Autoship creates switching inertia, but the underlying products are commodities that a larger logistics network can ship as cheaply or cheaper. A subscription habit is a real advantage, not an impregnable one.
The growth math is where the premium gets uncomfortable. The reverse-DCF reads the price as requiring roughly 29% operating-income growth, an elevated assumption with the fade check tripped, meaning the implied path sits above what the model expects to sustain. Yet the company itself guided active customer additions toward the lower end of its 150,000 to 250,000 per-quarter range, citing the current environment, and full-year net sales growth of only about 6.3% to 7.5%. A 29% earnings-growth requirement on a business adding customers at a low-single-digit rate is a gap, and the way to close it is margin expansion, which has a ceiling in thin-margin retail.
The valuation methods anchored to current economics make the disconnect concrete. Earnings power value lands at $0.39 because the normalized operating margin is so thin, the Graham number at $3.70, and the simple excess-return at $6.58, all far below the $18.21 price (June 27, 2026). Stock-based compensation is also material, consuming roughly half of free cash flow, so the SBC-adjusted FCF value of $6.22 is well under the headline. The bear read is that Chewy is a good business priced as a great one: the Autoship moat is real but eroding at the edges, the customer-growth engine has slowed, and the premium multiple needs a margin and growth combination that the company's own guidance does not promise.
Valuation
Chewy's valuation X-ray shows the signature of a durability bet: the static methods sit below the $18.21 price and only the growth frames reach it. Asset-based approaches land low, with the simple excess-return at $6.58 and the Graham number at $3.70, both depressed by a book value per share of only $1.01. Earnings-power frames are lower still, with earnings power value at $0.39 because the normalized operating margin is razor-thin. Peer multiples cluster nearer the price, relative valuation at $13.20 and EV/EBITDA relative at $13.40.
That pattern means the price is paying for compounding the static frames cannot see, which for Chewy is the Autoship recurring base. The reverse-DCF puts the implied operating-income growth near 29%, an elevated read with the fade check tripped, signaling the market expects durable high growth.
The honest synthesis is that Chewy trades right at its base fair value, which is a fair price for a moat that holds and a stretched one if it does not. The blended multiple of about 22.4x and the 29% implied growth are demanding for a business guiding to high-single-digit revenue growth and customer additions at the low end of its range. The case rests on margin expansion, the 130 basis points of EBITDA-margin gain in Q1 is the proof point, continuing while the recurring base stays sticky. A buyer at $18.21 is paying full value for the durability thesis, with a clean, net-cash balance sheet as the cushion and competition plus slowing customer growth as the risks.
Catalysts
The Q1 2026 report on June 10 was the most recent catalyst and a solid one: net sales up 7.7% to roughly $3.6 billion, a record 7.5% adjusted EBITDA margin, and nearly 200,000 net new active customers reaching 21.5 million. Autoship sales grew over 10% to 84.4% of the mix. The company maintained full-year adjusted EBITDA margin guidance of 6.6% to 6.8% and net sales of about $13.40 to $13.55 billion. The next quarterly print tests whether margin expansion continues against a softer customer-add backdrop.
The forward watch items are specific. First, active customer growth, which management guided toward the low end of its 150,000 to 250,000 per-quarter range citing the current environment; reaccelerating adds would validate the growth premium. Second, the adjusted EBITDA margin trajectory, since the premium multiple needs continued margin expansion and Q1 delivered 130 basis points. Third, Autoship penetration and net sales per active customer, the durability metrics that justify valuing Chewy on forward compounding. Fourth, the competitive response from Amazon, Walmart, and pet pharmacies, the moat-erosion risk that would pressure both growth and margin. Capital allocation is a quieter factor: the company holds net cash and has begun returning capital, so buyback pace against material stock-based compensation is worth tracking.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- W (WAYFAIR INC.)
- FY2025 10-K: Part I, Item 1, Business . 22 Table of Contents We expect competition in e-commerce generally to continue to increase. We believe that our ability to compete successfully depends upon many factors both within and beyond our control, including: • the size and composition of our customer base; • the number of suppliers…
- FY2025 10-K: …and trends. We believe these measures are useful indicators of the economic impact of orders fulfilled through our omni-channel platform because they take into account the direct expenses associated with generating and servicing customer demand. These measures provide additional visibility into unit-level performance…
- CPNG (COUPANG, INC.)
- FY2025 10-K: …We operate in a highly competitive industry and we may be unsuccessful in competing against current and future competitors, which could have a negative impact on the success of our business. The industry in which we operate is intensely competitive and we expect that competition will continue to increase. We…
- FY2025 10-K: …of service related to their products and services in a manner that impacts our competitive offerings. If we are unable to use or adapt to operational changes in such services, we may face higher costs for such services, encounter integration or technological barriers, or lose customers, which could cause our…
- CENT (Central Garden & Pet Company)
- FY2025 10-K: …which are more established in their industries and have substantially greater revenue and resources than we do. Our products compete against national and regional products and private label products produced by various suppliers. Our largest competitors in the Pet segment are Spectrum Brands, Mars, Inc. and the J.M…
- FY2025 10-K: …rapidly. To the extent that the key retailers, including retailers in the pet specialty segment, on which we depend lose share to the eCommerce channel, we could lose sales. We continue to make additional investments to access this channel more effectively, but there can be no assurances that any such investments…
- FRPT (FRESHPET, INC.)
- FY2025 10-K: …competition from competitors' products that are sometimes sold at lower prices. Price gaps between our products and our competitors' products may result in market share erosion and harm our business. A number of our competitors have broader product lines, substantially greater financial and other resources and/or…
- FY2025 10-K: …reportable segment: the manufacturing, marketing and distribution of fresh dog food, cat food, and dog treats. 41 Table of Contents ITEM 7a. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS Interest Rate Risk During periods of rising interest rates, our cost of borrowing could increase, the fair value of…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.